CCT3 and Miyoshi myopathy: The disease is characterized by monoclonal proliferation of plasma cells, leading to the production of monoclonal antibodies and end-organ damage, which causes hypercalcemia, kidney impairment, anemia, and bone lesions.[84] CCT3 is highly expressed in MM tissues and is associated with poor prognosis.